Equol
Flavonoid activator of CFTR
General information
Equol is an isoflavandiol estrogen metabolized from a type of isoflavone in soybeans and other plant sources by bacterial flora in the intestines. It is being developed as a treatment of menopausal symptoms and studies also in terms of breast cancer treatment. In relation to cystic fibrosis, our AIM tool found the data that equol can help activate F508del-CFTR.
Equol on PubChem
Equol on DrugBank
Synonyms
4',7-isoflavandiol
Marketed as
N/A
Dietary sources
soybeans
C15H14O3
Drug-Mutation Relation
results for D1152H / F508del
See all data on EquolTreats
| Mutation | Link | Tested on | Impact factor | Notes |
|---|---|---|---|---|
| F508del | Activation of the Cystic Fibrosis Transmembrane Conductance Regulator by the Flavonoid Quercetin | human cell cultures | 4.43 | Less safe than quercetin. |
Does not treat
| Mutation | Link | Tested on | Impact factor | Notes |
|---|